Two clinical studies presented at the 2026 Science of Skin Summit demonstrated that targeted skincare regimens and DiamondGlow® dermabrasion treatments significantly improved skin quality in individuals using medical weight loss medications like GLP-1 receptor agonists. Participants showed visible improvements in dryness, skin tone, texture, and youthful appearance, with some reporting their skin looked up to 10 years younger after treatment. These findings highlight potential aesthetic benefits for patients undergoing medical weight loss, with further research needed to confirm results in larger groups.
The new clinical data on skin quality improvements related to medical weight loss medications provides context for health sector trends. For readers following health stocks, here is Pluang's market snapshot as of Sep 17, 2026 18:11 WIB: Of 91 priced health-sector US stocks tradable on Pluang, 63 rose and 25 fell today. Notable movers include ASND at USD 239.50 with a 1-day change of -3.31% and a typical hold time of 55 days, SANA at USD 3.00 up 2.74% with a 22-day hold time, and TWST at USD 146.86 up 2.65% with a 28-day hold time.
Ciena reported a 37% revenue increase to $1.67 billion and a 215% rise in adjusted EPS to $2.11 in its fiscal third quarter, driven by strong demand from AI and cloud infrastructure. The company is well positioned to benefit from the AI networking ma...
Maureen Gellerman, Chief Human Resources Officer at Five Below, sold 1,610 shares of the company, generating $401,000 from the transaction. This insider sale may indicate personal financial planning or portfolio rebalancing but does not necessarily r...
ON Semiconductor is focusing on advanced power-density technologies for AI data centers and electric vehicles, aiming for $2.5 billion revenue from AI alone by 2030. Despite a Neutral rating from UBS, the company introduced its Embedded Power Platfor...
Salesforce, a leader in cloud-based CRM software, is driving future growth with its new AIforce platform and ambitious financial goals. The company aims to exceed $63 billion in revenue by 2030, reflecting strong demand for its AI and core software p...
Oscar Health's stock has surged 126% this year, driven by a 47% increase in ACA marketplace enrollment despite overall market declines. The company, now the second-largest insurer on the ACA exchange, has raised its earnings outlook and improved its ...
